{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:18:30Z","timestamp":1792289910866,"version":"4.4.0"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Acute graft-versus-host disease (aGVHD) is a rare but potentially life-threatening complication that can occur after solid organ transplantation, particularly in organs with abundant lymphoid tissue like the liver and intestines. While less common in lung transplants, the rising numbers of these procedures have brought more attention to aGVHD, usually appearing within the first 3-mo posttransplant. Given its relative rarity, a clear understanding of the pathophysiology, risk factors, diagnostic, and management strategies remain elusive. These knowledge gaps can lead to delays in diagnosis and the initiation of appropriate treatment leading to predictably inferior outcomes. Managing aGVHD following solid organ transplantation is challenging, and there is no standard approach. Current management involves high-dose steroids and other immunosuppressive drugs. However, these interventions are associated with serious complications, including potentially fatal infections, underscoring the urgent need for more research to refine both diagnostic methods and treatment approaches and ultimately improving patient outcomes. In this report, we aim to deepen our understanding of aGVHD following lung transplants and share our experience with a unique case of aGVHD occurring almost a year after lung transplantation that was successfully managed using ruxolitinib, describing a potential treatment approach modeled on the contemporary management of stem cell transplant associated aGVHD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000005226","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T02:00:32Z","timestamp":1728352832000},"page":"e248-e252","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Treatment of Late-onset Acute Graft-versus-host Disease Following Double Lung Transplantation Using a JAK2 Inhibitor"],"prefix":"10.1097","volume":"109","author":[{"given":"Ruah","family":"Alyamany","sequence":"first","affiliation":[{"name":"Hans Messner Allogeneic Blood and Marrow Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada."},{"name":"Department of Hematology, Stem Cell Transplant and Cellular Therapy, Oncology Centre, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Alnughmush","sequence":"additional","affiliation":[{"name":"Hans Messner Allogeneic Blood and Marrow Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada."},{"name":"Department of Hematology, Stem Cell Transplant and Cellular Therapy, Oncology Centre, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Albaiz","sequence":"additional","affiliation":[{"name":"Division of Respirology, Toronto Lung Transplant Program, University Health Network, Toronto, ON, Canada."},{"name":"Lung Heath Centre, Organ Transplant Center of Excellence, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Aversa","sequence":"additional","affiliation":[{"name":"Division of Respirology, Toronto Lung Transplant Program, University Health Network, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Law","sequence":"additional","affiliation":[{"name":"Hans Messner Allogeneic Blood and Marrow Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada."},{"name":"Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,10,8]]},"reference":[{"key":"R1-20250714","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1016\/j.chest.2016.05.017","article-title":"A 48-year-old man with leukopenia, jaundice, and skin rash after lung transplantation.","volume":"150","author":"Ataya","year":"2016","journal-title":"Chest"},{"key":"R2-20250714","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/cup.13326","article-title":"Clinical and histopathologic manifestations of solid organ transplantation-associated graft-versus-host disease involving the skin: a single-center retrospective study.","volume":"45","author":"Kim","year":"2018","journal-title":"J Cutan Pathol"},{"key":"R3-20250714","doi-asserted-by":"crossref","first-page":"e27477","DOI":"10.1002\/pbc.27477","article-title":"Cladribine-related immunosuppression may have fostered graft-versus-host disease after lung transplant for pulmonary Langerhans cell histiocytosis.","volume":"66","author":"Galambrun","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"R4-20250714","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0012.2006.00573.x","article-title":"Graft-vs.-host disease in lung and other solid organ transplant recipients.","volume":"21","author":"Assi","year":"2007","journal-title":"Clin Transplant"},{"key":"R5-20250714","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S1053-2498(02)00811-2","article-title":"Graft-versus-host disease in lung transplantation: 4 case reports and literature review.","volume":"22","author":"Luckraz","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"R6-20250714","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.healun.2006.05.008","article-title":"Graft-vs-host disease as a complication of lung transplantation.","volume":"25","author":"Smith","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"R7-20250714","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.healun.2009.01.023","article-title":"Severe acute graft versus host disease after lung transplant: report of a case successfully treated with high dose corticosteroids.","volume":"28","author":"Fossi","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"R8-20250714","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jdcr.2021.05.009","article-title":"Acute graft-versus-host disease after double lung transplantation.","volume":"13","author":"Kim","year":"2021","journal-title":"JAAD Case Rep"},{"key":"R9-20250714","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1097\/01.TP.0000145523.08548.48","article-title":"Recipients who receive a human leukocyte antigen-B compatible cadaveric liver allograft are at high risk of developing acute graft-versus-host disease.","volume":"78","author":"Key","year":"2004","journal-title":"Transplantation"},{"key":"R10-20250714","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJM198803173181107","article-title":"Severe graft-versus-host disease in a liver-transplant recipient.","volume":"318","author":"Burdick","year":"1988","journal-title":"N Engl J Med"},{"key":"R11-20250714","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00007890-200301150-00022","article-title":"Liver transplant-associated graft-versus-host disease.","volume":"75","author":"Smith","year":"2003","journal-title":"Transplantation"},{"key":"R12-20250714","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/lt.21082","article-title":"Recipient and donor factors influence the incidence of graft-vs.-host disease in liver transplant patients.","volume":"13","author":"Chan","year":"2007","journal-title":"Liver Transplant"},{"key":"R13-20250714","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/j.1600-6143.2004.00524.x","article-title":"Graft versus host disease in intestinal transplantation.","volume":"4","author":"Mazariegos","year":"2004","journal-title":"Am J Transplant"},{"key":"R14-20250714","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1600-6143.2004.00406.x","article-title":"Acute graft versus host disease following liver transplantation: the enemy within.","volume":"4","author":"Taylor","year":"2004","journal-title":"Am J Transplant"},{"key":"R15-20250714","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1537-2995.2001.41030419.x","article-title":"Microchimerism, GVHD, and tolerance in solid organ transplantation.","volume":"41","author":"Triulzi","year":"2001","journal-title":"Transfusion"},{"key":"R16-20250714","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jaad.2017.12.050","article-title":"Dermatologic manifestations of solid organ transplantation\u2013associated graft-versus-host disease: a systematic review.","volume":"78","author":"Kim","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R17-20250714","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/01.TP.0000103721.29729.FE","article-title":"Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease after liver transplantation.","volume":"77","author":"Taylor","year":"2004","journal-title":"Transplantation"},{"key":"R18-20250714","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1309\/395BX683QFN6CJBC","article-title":"Graft-vs-host disease after solid organ transplant.","volume":"119","author":"Wick","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"R19-20250714","first-page":"67","article-title":"A simple method for inducing tolerance of skin homografts in mice.","volume":"4","author":"Billingham","year":"1957","journal-title":"Transplant Bull"},{"key":"R20-20250714","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.5858\/2008-0679-RS.1","article-title":"Solid organ transplant-associated acute graft-versus-host disease.","volume":"134","author":"Zhang","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"R21-20250714","doi-asserted-by":"crossref","first-page":"S324","DOI":"10.1016\/j.jaci.2009.11.014","article-title":"Transplantation immunology: solid organ and bone marrow.","volume":"125","author":"Chinen","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"R22-20250714","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jdcr.2023.03.016","article-title":"Acute graft-versus-host disease after double lung transplant confirmed by short tandem repeat analysis to identify donor chimerism in the skin.","volume":"36","author":"Valencia","year":"2023","journal-title":"JAAD Case Rep"},{"key":"R23-20250714","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/thoraxjnl-2017-211121","article-title":"Acute graft-versus-host disease following lung transplantation in a patient with a novel TERT mutation.","volume":"73","author":"Brestoff","year":"2018","journal-title":"Thorax"},{"key":"R24-20250714","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/lt.20573","article-title":"Fatal graft-versus-host disease after living donor liver transplantation: differential impact of donor-dominant one-way HLA matching.","volume":"12","author":"Kamei","year":"2006","journal-title":"Liver Transplant"},{"key":"R25-20250714","first-page":"64","article-title":"Colonic graft-versus-host disease.","volume":"21","author":"Ross","year":"2005","journal-title":"Curr Opin Gastroenterol"},{"key":"R27-20250714","doi-asserted-by":"crossref","first-page":"e00287","DOI":"10.14309\/crj.0000000000000287","article-title":"Graft-vs-host disease colitis after lung transplant.","volume":"6","author":"Kanthasamy","year":"2019","journal-title":"ACG Case Rep J"},{"key":"R28-20250714","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0022-5223(97)70159-4","article-title":"Acute graft-versus-host disease after human heart-lung transplantation: a case report.","volume":"114","author":"Pfitzmann","year":"1997","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R29-20250714","first-page":"5240","article-title":"Graft-versus-host disease after liver transplantation: a comprehensive literature review.","volume":"18","author":"Akbulut","year":"2012","journal-title":"World J Gastroenterol"},{"key":"R30-20250714","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1111\/j.1600-6143.2005.01110.x","article-title":"Acute graft versus host disease after liver transplantation: patterns of lymphocyte chimerism.","volume":"5","author":"Domiati-Saad","year":"2005","journal-title":"Am J Transplant"},{"key":"R31-20250714","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0167-5699(96)10069-4","article-title":"Chimerism and transplantation tolerance: cause and effect.","volume":"17","author":"Wood","year":"1996","journal-title":"Immunol Today"},{"key":"R32-20250714","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/0140-6736(92)91840-5","article-title":"Cell migration, chimerism, and graft acceptance.","volume":"339","author":"Starzl","year":"1992","journal-title":"Lancet"},{"key":"R33-20250714","doi-asserted-by":"crossref","first-page":"e492","DOI":"10.1111\/ijd.12149","article-title":"Absence of peripheral blood chimerism in graft-vs-host disease following orthotopic liver transplantation: case report and review of the literature.","volume":"53","author":"Schulman","year":"2014","journal-title":"Int J Dermatol"},{"key":"R34-20250714","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1097\/TP.0000000000001406","article-title":"Graft versus host disease after liver transplantation in adults: a case series, review of literature, and an approach to management.","volume":"100","author":"Murali","year":"2016","journal-title":"Transplantation"},{"key":"R35-20250714","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.4049\/jimmunol.146.10.3523","article-title":"Abrogation of glucocorticoid-mediated inhibition of T cell proliferation by the synergistic action of IL-1, IL-6, and IFN-gamma.","volume":"146","author":"Almawi","year":"1991","journal-title":"J Immunol"},{"key":"R36-20250714","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1182\/blood.2022015954","article-title":"How I diagnose and treat acute graft-versus-host disease after solid organ transplantation.","volume":"141","author":"Cooper","year":"2023","journal-title":"Blood"},{"key":"R37-20250714","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/trf.13467","article-title":"Extracorporeal photopheresis in solid organ transplant\u2013associated acute graft-versus-host disease.","volume":"56","author":"Houston","year":"2016","journal-title":"Transfusion"},{"key":"R38-20250714","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/j.bbmt.2015.07.007","article-title":"Treatment of acute graft-versus-host disease in childhood with extracorporeal photochemotherapy\/photopheresis: the Padova experience.","volume":"21","author":"Calore","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"R39-20250714","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1182\/blood-2005-09-3907","article-title":"Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.","volume":"107","author":"Couriel","year":"2006","journal-title":"Blood"},{"key":"R40-20250714","first-page":"1","article-title":"Management of acute graft-versus-host disease.","volume":"6","author":"Deeg","year":"1990","journal-title":"Bone Marrow Transplant"},{"key":"R41-20250714","first-page":"974","article-title":"Mediastinal irradiation for graft-versus-host disease in a heart-lung transplant recipient.","volume":"16","author":"Chau","year":"1997","journal-title":"J Heart Lung Transplant"},{"key":"R42-20250714","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1432-2277.2007.00625.x","article-title":"Graft versus host disease after liver transplantation\u2014a single center experience and review of literature.","volume":"21","author":"Kohler","year":"2008","journal-title":"Transpl Int"},{"key":"R43-20250714","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/ajt.15579","article-title":"The use of ruxolitinib for acute graft-versus-host disease developing after solid organ transplantation.","volume":"20","author":"Jacobs","year":"2020","journal-title":"Am J Transplant"},{"key":"R44-20250714","doi-asserted-by":"crossref","first-page":"e109799","DOI":"10.1371\/journal.pone.0109799","article-title":"Pharmacologic blockade of JAK1\/JAK2 reduces GvHD and preserves the graft-versus-leukemia effect.","volume":"9","author":"Choi","year":"2014","journal-title":"PLoS One"},{"key":"R45-20250714","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1182\/blood-2012-01-403196","article-title":"IFN\u03b3R signaling mediates alloreactive T-cell trafficking and GVHD.","volume":"120","author":"Choi","year":"2012","journal-title":"Blood"},{"key":"R46-20250714","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1182\/blood.2020004823","article-title":"Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial.","volume":"135","author":"Jagasia","year":"2020","journal-title":"Blood"},{"key":"R47-20250714","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1172\/JCI43706","article-title":"Absence of Stat1 in donor CD4+ T cells promotes the expansion of Tregs and reduces graft-versus-host disease in mice.","volume":"134","author":"Ma","year":"2011","journal-title":"J Clin Investig"},{"key":"R48-20250714","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cellimm.2011.01.008","article-title":"Sequential activation of inflammatory signaling pathways during graft-versus-host disease (GVHD): early role for STAT1 and STAT3.","volume":"268","author":"Ma","year":"2011","journal-title":"Cell Immunol"},{"key":"R49-20250714","doi-asserted-by":"crossref","first-page":"1304065","DOI":"10.3389\/fimmu.2024.1304065","article-title":"Janus kinase inhibition in the treatment and prevention of graft-versus-host disease.","volume":"15","author":"De Togni","year":"2024","journal-title":"Front Immunol"},{"key":"R50-20250714","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa2033122","article-title":"Ruxolitinib for glucocorticoid-refractory chronic graft-versus-host disease.","volume":"385","author":"Zeiser","year":"2021","journal-title":"N Engl J Med"},{"key":"R51-20250714","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa1917635","article-title":"Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease.","volume":"382","author":"Zeiser","year":"2020","journal-title":"N Engl J Med"},{"key":"R52-20250714","article-title":"Highlights of prescribing information for Jakafi, Incyte Corporation."},{"key":"R53-20250714","doi-asserted-by":"crossref","first-page":"107005","DOI":"10.1016\/j.leukres.2022.107005","article-title":"Ruxolitinib-induced reactivation of cytomegalovirus and Epstein-Barr virus in graft-versus-host disease.","volume":"125","author":"Lebon","year":"2023","journal-title":"Leuk Res"},{"key":"R54-20250714","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41409-019-0731-x","article-title":"Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study.","volume":"55","author":"Escamilla G\u00f3mez","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"R55-20250714","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1182\/blood.2021012021","article-title":"Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar study.","volume":"138","author":"Cutler","year":"2021","journal-title":"Blood"},{"key":"R56-20250714","first-page":"1098","article-title":"Catastrophic graft-versus-host disease after lung transplantation proven by PCR-based chimerism analysis.","volume":"21","author":"Worel","year":"2008","journal-title":"Transpl Int"},{"key":"R57-20250714","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1309\/395BX683QFN6CJBC","article-title":"Graft-vs-host disease after solid organ transplant.","volume":"119","author":"Gulbahce","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"R58-20250714","first-page":"2519","article-title":"Lymphocyte chimaerism after organ transplantation.","volume":"24","author":"Joysey","year":"1992","journal-title":"Transplant Proc"},{"key":"R59-20250714","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1097\/01.TP.0000144183.77279.EC","article-title":"Control of organ transplant-associated graft-versus-host disease by activated host lymphocyte infusions.","volume":"78","author":"Kuball","year":"2004","journal-title":"Transplantation"},{"key":"R60-20250714","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1034\/j.1399-0012.2000.140213.x","article-title":"Graft-versus-host disease after liver transplantation: documentation by fluorescent in situ hybridisation and human leucocyte antigen typing.","volume":"14","author":"Au","year":"2000","journal-title":"Clin Transplant"},{"key":"R61-20250714","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/00007890-198912000-00001","article-title":"Immune mechanisms in cyclosporine-induced syngeneic graft-versus-host disease.","volume":"48","author":"Hess","year":"1989","journal-title":"Transplantation"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005226","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T20:00:41Z","timestamp":1752523241000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,8]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005226","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,8]]}}}